Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Aims For Greater Efficiency Under Modular PMA Revamp

This article was originally published in The Gray Sheet

Executive Summary

FDA wants to limit the number of premarket components sponsors can submit under its modular PMA program in order to ensure efficient use of its device review resources.
Advertisement

Related Content

User Fee Proposals Elicit Cautious Response From Device Center Director
User Fee Proposals Elicit Cautious Response From Device Center Director
ODE Looks To FY 2002 Budget To Fill Vacancies Left By Departing Staff
ODE Looks To FY 2002 Budget To Fill Vacancies Left By Departing Staff
CDRH PMA Review Performance Improves In FY 2000 Wrap-Up
CDRH PMA Review Performance Improves In FY 2000 Wrap-Up
Advertisement
UsernamePublicRestriction

Register

MT013929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel